Cargando…

Expression of Concern: FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2022
Materias:	Expression of Concern
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661373/ https://www.ncbi.nlm.nih.gov/pubmed/36367178 http://dx.doi.org/10.1042/BSR-2015-0032_EOC

Ejemplares similares

FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity
por: Xin, Yan-Le, et al.
Publicado: (2015)

Monoamine Depletion by Reuptake Inhibitors [Expression of Concern]
Publicado: (2020)

FSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanisms
por: Li, Yan-Hua, et al.
Publicado: (2017)

Expression of Concern: Long non-coding RNA linc-ITGB1 promotes cell proliferation, migration and invasion in human hepatoma carcinoma by upregulating ROCK1
Publicado: (2021)

Editorial Expression of Concern: Asymmetrical than symmetrical cerebral arterial bifurcations are more vulnerable to aneurysm presence
por: Zhang, Xue-Jing, et al.
Publicado: (2022)

Expression of Concern: Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene
Publicado: (2023)

EXPRESSION OF CONCERN: ‘Total glucosides of paeony suppresses experimental autoimmune uveitis in association with inhibition of Th1 and Th2 cell function in mice’
Publicado: (2021)

Long Noncoding RNA KCNMB2-AS1 Increases ROCK1 Expression by Sponging microRNA-374a-3p to Facilitate the Progression of Non–Small-Cell Lung Cancer [Expression of Concern]
Publicado: (2021)

Expression of concern: Compensatory increase of transglutaminase 2 is responsible for resistance to mTOR inhibitor treatment
Publicado: (2020)

Expression of concern
Publicado: (2013)

Expression of Concern
Publicado: (2016)

Expression of Concern
Publicado: (2015)

Expression of concern
Publicado: (2018)

Expression of concern
Publicado: (2020)

Expression of Concern
Publicado: (2020)

Expression of Concern
Publicado: (2015)

Expression of concern
Publicado: (2021)

Expression of Concern
Publicado: (2022)

Expression of Concern
Publicado: (2022)

Expression of Concern
Publicado: (2023)

Expression of Concern: Mixed lineage leukaemia histone methylases 1 collaborate with ERα to regulate HOXA10 expression in AML
Publicado: (2021)

Expression of Concern: Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine
Publicado: (2012)

Expression of Concern: Imbalance of Circulating Monocyte Subsets and PD-1 Dysregulation in Q Fever Endocarditis: The Role of IL-10 in PD-1 Modulation
Publicado: (2022)

Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Publicado: (2019)

Expression of concern: “Humoral immune mechanisms involved in protective and pathological immunity during COVID-19” [Hum. Immunol. 82(10) (2021) 733–745]
por: Widjaja, Gunawan, et al.
Publicado: (2023)

Expression of Concern. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
por: Prada, Patricia O., et al.
Publicado: (2017)

The Discrediting of the Monoamine Hypothesis [Expression of Concern]
Publicado: (2020)

Expression of Concern. Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase. Diabetes 2011;60:138–147. DOI: 10.2337/db10-0860. PMID: 20864515
por: Oriente, Francesco, et al.
Publicado: (2018)

5-HTP Efficacy and Contraindications [Expression of Concern]
Publicado: (2020)

Expression of Concern: Inhibition in the Human Auditory Cortex
Publicado: (2023)

Expression of Concern on “IκB Kinase Inhibitor VII Modulates Sepsis-Induced Excessive Inflammation and Cardiac Dysfunction in 5/6 Nephrectomized Mice”
por: Inflammation, Mediators of
Publicado: (2023)

Expression of Concern to: Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
Publicado: (2022)

Ex pression of Concern: Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
Publicado: (2023)

Expression of concern for Euro Surveill. 2020;25(33)
Publicado: (2020)

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
Publicado: (2020)

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
Publicado: (2020)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
Publicado: (2020)

Expression of Concern on “Ubiquinol Improves Symptoms in Children with Autism”
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2020)

Expression of Concern: Rickettsia Species in African Anopheles Mosquitoes
Publicado: (2022)

Expression of Concern: Complexin in ivermectin resistance in body lice
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9e69dk3pt5b7ljpvq7l76qthrl